loading
Inovio Pharmaceuticals Inc stock is traded at $2.10, with a volume of 693.60K. It is up +5.00% in the last 24 hours and up +9.38% over the past month. Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
See More
Previous Close:
$2.00
Open:
$2.03
24h Volume:
693.60K
Relative Volume:
1.13
Market Cap:
$77.01M
Revenue:
$832.00K
Net Income/Loss:
$-135.12M
P/E Ratio:
-0.3448
EPS:
-6.09
Net Cash Flow:
$-124.69M
1W Performance:
+6.60%
1M Performance:
+9.38%
6M Performance:
-51.72%
1Y Performance:
-79.27%
1-Day Range:
Value
$2.00
$2.155
1-Week Range:
Value
$1.955
$2.27
52-Week Range:
Value
$1.42
$12.33

Inovio Pharmaceuticals Inc Stock (INO) Company Profile

Name
Name
Inovio Pharmaceuticals Inc
Name
Phone
(858) 410-3134
Name
Address
660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA
Name
Employee
134
Name
Twitter
@inoviopharma
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
INO's Discussions on Twitter

Compare INO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
INO
Inovio Pharmaceuticals Inc
2.10 73.35M 832.00K -135.12M -124.69M -6.09
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.93 25.76B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.43 114.53B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.415 40.54M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
84.10 6.44B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.81 65.13B 14.09B 4.50B 2.96B 39.28

Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades

Date Action Analyst Rating Change
May-14-24 Initiated Stephens Overweight
Jan-25-24 Upgrade Oppenheimer Perform → Outperform
Nov-09-22 Downgrade Maxim Group Buy → Hold
Nov-01-22 Downgrade BofA Securities Neutral → Underperform
Jul-19-22 Resumed RBC Capital Mkts Sector Perform
May-11-22 Downgrade Oppenheimer Outperform → Perform
Jan-21-22 Upgrade BofA Securities Underperform → Neutral
Dec-29-21 Resumed Jefferies Hold
Sep-10-21 Downgrade BofA Securities Neutral → Underperform
Jun-24-21 Initiated Jefferies Hold
Mar-23-21 Initiated BofA Securities Neutral
Feb-12-21 Initiated Oppenheimer Outperform
Nov-17-20 Downgrade ROTH Capital Neutral → Sell
Nov-10-20 Upgrade ROTH Capital Sell → Neutral
Sep-28-20 Downgrade Cantor Fitzgerald Overweight → Neutral
Sep-28-20 Upgrade Maxim Group Hold → Buy
Jul-01-20 Downgrade Maxim Group Buy → Hold
Jul-01-20 Downgrade ROTH Capital Neutral → Sell
Jun-29-20 Downgrade H.C. Wainwright Buy → Neutral
Jun-26-20 Downgrade Stifel Buy → Hold
May-21-20 Initiated The Benchmark Company Buy
Apr-30-20 Downgrade ROTH Capital Buy → Neutral
Mar-13-20 Downgrade Piper Sandler Overweight → Neutral
Mar-13-20 Downgrade RBC Capital Mkts Outperform → Sector Perform
Dec-19-19 Initiated ROTH Capital Buy
Feb-15-18 Reiterated Maxim Group Buy
Oct-18-17 Initiated RBC Capital Mkts Outperform
Sep-06-17 Initiated Citigroup Buy
Jun-08-17 Upgrade Piper Jaffray Neutral → Overweight
May-24-17 Reiterated Maxim Group Buy
Mar-16-17 Upgrade Maxim Group Hold → Buy
Mar-16-17 Downgrade Piper Jaffray Overweight → Neutral
View All

Inovio Pharmaceuticals Inc Stock (INO) Latest News

pulisher
May 30, 2025

Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch

May 30, 2025
pulisher
May 27, 2025

Inovio’s SWOT analysis: dna immunotherapy firm faces crucial year for stock - Investing.com Australia

May 27, 2025
pulisher
May 23, 2025

Inovio shareholders approve board nominees and proposals By Investing.com - Investing.com Canada

May 23, 2025
pulisher
May 22, 2025

Inovio shareholders approve board nominees and proposals - Investing.com Australia

May 22, 2025
pulisher
May 22, 2025

Inovio Pharmaceuticals Holds Annual Stockholders Meeting - TipRanks

May 22, 2025
pulisher
May 19, 2025

INOVIO Reports Q1 2025 Results and Key Developments in DNA Medicines - MyChesCo

May 19, 2025
pulisher
May 17, 2025

Q2 EPS Estimate for Inovio Pharmaceuticals Cut by Analyst - Defense World

May 17, 2025
pulisher
May 16, 2025

Inovio Pharmaceuticals (INO) Reports Q1 Loss, Tops Revenue Estimates - MSN

May 16, 2025
pulisher
May 15, 2025

Inovio Pharmaceuticals’ Earnings Call: Progress Amid Challenges - TipRanks

May 15, 2025
pulisher
May 15, 2025

Inovio Pharmaceuticals (INO) Sees Price Target Adjustment by Opp - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Inovio outlines BLA submission timeline for INO-3107 and reports $68.4M cash position while advancing DNA medicine pipeline - MSN

May 15, 2025
pulisher
May 14, 2025

Inovio Pharmaceuticals (INO) Maintains Sector Perform Rating by RBC Capital | INO Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Oppenheimer cuts Inovio stock price target to $13 By Investing.com - Investing.com Nigeria

May 14, 2025
pulisher
May 14, 2025

INO Reports Strong Q1 Revenue, Progress on INO-3107 Submission | - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q1 2025 Earnings Call Transcript - Insider Monkey

May 14, 2025
pulisher
May 14, 2025

Inovio (INO) Receives Revised Price Target from Oppenheimer | IN - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Inovio Pharmaceuticals: Hold Rating Due to Financial Losses and Uncertain Development Timeline - TipRanks

May 14, 2025
pulisher
May 14, 2025

Inovio stock holds $12 target, JMP affirms Market Outperform By Investing.com - Investing.com Canada

May 14, 2025
pulisher
May 14, 2025

Inovio stock holds $12 target, JMP affirms Market Outperform - Investing.com Australia

May 14, 2025
pulisher
May 14, 2025

Inovio Pharmaceuticals Inc (INO) Q1 2025 Earnings Call Highlights: Strategic Cost Management ... - Yahoo Finance

May 14, 2025
pulisher
May 14, 2025

Inovio Pharmaceuticals Q1 2025 Earnings Call Transcript - MarketBeat

May 14, 2025
pulisher
May 13, 2025

Inovio Pharmaceuticals (INO) Advances BLA Submission for INO-310 - GuruFocus

May 13, 2025
pulisher
May 13, 2025

INOVIO Reports First Quarter 2025 Financial Results and Recent B - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Earnings call transcript: Inovio’s Q1 2025 sees narrowed losses, stock rises - Investing.com India

May 13, 2025
pulisher
May 13, 2025

Inovio: Q1 Earnings Snapshot - San Francisco Chronicle

May 13, 2025
pulisher
May 13, 2025

Inovio Pharmaceuticals Inc (INO) Q1 2025 Earnings: EPS of -$0.51 - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Inovio Pharmaceuticals Q1 Operating Expenses USD 25.1 Million - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights - PR Newswire

May 13, 2025
pulisher
May 13, 2025

Inovio Pharmaceuticals Q1 25 Earnings Conference Call At 4:30 PM ET - Nasdaq

May 13, 2025
pulisher
May 13, 2025

Options Volatility and Implied Earnings Moves Today, May 13, 2025 - The Globe and Mail

May 13, 2025
pulisher
May 13, 2025

Inovio Pharmaceuticals (NASDAQ:INO) Lowered to “Sell” Rating by StockNews.com - Defense World

May 13, 2025
pulisher
May 13, 2025

INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights | INO Stock News - GuruFocus

May 13, 2025
pulisher
May 11, 2025

Inovio Pharmaceuticals (INO) Expected to Announce Quarterly Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 08, 2025

Inovio at The Citizens JMP Life Sciences Conference: DNA Platform Progress - Investing.com Australia

May 08, 2025
pulisher
May 05, 2025

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Shares Sold by Renaissance Technologies LLC - Defense World

May 05, 2025
pulisher
May 05, 2025

Inovio Pharmaceuticals (NASDAQ:INO) Cut to Sell at StockNews.com - Defense World

May 05, 2025
pulisher
May 03, 2025

INOVIO to Report First Quarter 2025 Financial Results on May 13, 2025 - Kilgore News Herald

May 03, 2025
pulisher
May 02, 2025

Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

May 02, 2025
pulisher
May 02, 2025

INOVIO to Announce Q1 2025 Results and Host Live Webcast on May 13 - MyChesCo

May 02, 2025
pulisher
May 01, 2025

Geode Capital Management LLC Boosts Stake in Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Defense World

May 01, 2025
pulisher
May 01, 2025

INOVIO to Present at Upcoming Scientific and Investor Conferences - The Bradford Era

May 01, 2025
pulisher
Apr 30, 2025

INOVIO to Present at Upcoming Scientific and Investor Conferences | INO Stock News - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

XTX Topco Ltd Acquires New Position in Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Defense World

Apr 30, 2025

Inovio Pharmaceuticals Inc Stock (INO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$1.15
price up icon 6.48%
$31.19
price up icon 3.48%
$584.61
price up icon 1.98%
$306.09
price up icon 0.50%
$4.5994
price up icon 2.21%
$490.81
price up icon 0.11%
Cap:     |  Volume (24h):